OECD Member Countries are interested in increasing the use of omics technologies in regulatory toxicology to advance chemical risk assessment. In this context, the OECD has developed this Guidance Document and accompanying Excel template for reporting omics studies, which is referred to as the OECD Omics Reporting Framework (OORF). The OORF is intended to facilitate data sharing for omics toxicology experiments, increase the transparency of omics data processing approaches used, enable quality assessment of the study experiment and data, and promote reproducibility.
OECD Omics Reporting Framework (OORF): Guidance on reporting elements for the regulatory use of omics data from laboratory‑based toxicology studies
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
18 December 2025265 Pages
-
15 December 2025169 Pages
-
Report3 December 2025136 Pages
-
Report3 December 202594 Pages
-
2 June 202540 Pages
-
28 May 202591 Pages
Related publications
-
2 July 2026115 Pages
-
Report2 July 202632 Pages
-
2 July 202615 Pages
-
Report
Assay for the Detection of Glucocorticoid Receptor Agonist and Antagonist Activity of Chemicals
2 July 202634 Pages -
Report
Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins
2 July 202663 Pages -
Report
Assays addressing the Adverse Outcome Pathway Key Event on Keratinocyte activation
2 July 202698 Pages